McKesson stock trades near recent highs as investors digest FY27 outlook

McKesson Corporation stock (ISIN US58155Q1031) is trading around a chart signal of USD 874.65 as of September 19, 2026 on the NYSE, keeping the shares close to their recent high range while investors digest the company’s FY27 outlook and dividend policy.

Guidance and latest quarterly figures

According to MarketBeat on September 19, 2026, McKesson last reported its quarterly numbers for the first quarter of fiscal year 2027, posting earnings per share of USD 9.93 versus analyst consensus of USD 9.56, a beat of USD 0.37 per share.

In the same Q1 FY27 report, McKesson generated revenue of USD 105.38 billion compared with analyst estimates of USD 103.88 billion, implying a year over year revenue increase of 7.7 percent from the prior year’s USD 97.85 billion level in that quarter per MarketBeat.

The company’s Q1 FY27 net margin was reported at 1.12 percent, with the quarter’s revenue of USD 105.38 billion translating into approximately USD 1.18 billion of net income, underlining how small changes in margin can have a large impact on earnings for a high-volume distributor according to MarketBeat.

For the full fiscal year 2027, McKesson has set guidance for earnings per share in a range of USD 44.20 to USD 45.00, and sell side analysts on average expect EPS of about USD 44.64 for that year, which frames today’s valuation against a forward multiple according to MarketBeat.

Dividend increase and investor positioning

McKesson’s board has also approved a higher quarterly dividend, with the payout set at USD 0.94 per share to be paid on October 1, 2026 to shareholders of record on September 1, 2026, up from the previous quarterly dividend of USD 0.82 per share, representing an increase of roughly 14.6 percent according to MarketBeat.

On an annualized basis this new dividend corresponds to USD 3.76 per share, which translates into a forward dividend yield of about 0.4 percent at the prevailing share price range and a dividend payout ratio of roughly 10.06 percent of earnings, leaving most of the cash flow available for buybacks and reinvestment per MarketBeat.

The article on MarketBeat also highlights institutional activity, noting that Nykredit A S recently bought 48,302 shares of McKesson, which underscores continued interest from long term investors looking for exposure to the company’s scale and relatively defensive healthcare distribution model.

Chart signals and current stock level

A recent technical overview from Stock Traders Daily dated September 19, 2026 identified several volatility zones for McKesson, listing key signals at USD 769.17, USD 852.07, USD 874.65 and USD 939.11, with USD 874.65 marked as the current price level in its neutral sentiment framework.

Within that analysis, the position trading strategy highlighted a long entry zone around USD 852.07 with a target of USD 939.11 and a stop loss near USD 849.61, implying a potential gain of about 10.2 percent versus a defined downside risk of roughly 0.3 percent under the outlined risk reward setup according to Stock Traders Daily.

The same volatility zones report described neutral sentiment for near term, mid term and long term horizons, with support signals clustered between roughly USD 852 and USD 878 and resistance signals between approximately USD 892 and USD 939, suggesting that McKesson stock may continue to trade sideways in this wide corridor unless new fundamental developments shift expectations according to Stock Traders Daily.

Stock price and valuation snapshot

As of September 19, 2026, the most recent chart signal lists McKesson stock at USD 874.65 on the NYSE, placing the shares closer to the upper half of the highlighted trading channel and roughly midway between the identified support at USD 852.07 and resistance at USD 939.11 from the technical study, which investors use as a reference for short term positioning per Stock Traders Daily.

More news and analyses on McKesson Corporation stock